Millions of Surgery Records Raise New Questions About GLP-1 Drugs
Summary
Researchers studied over 2 million surgery patients and found that those taking GLP-1 drugs before elective surgery had fewer serious heart problems and infections after surgery. These medications, originally used for diabetes and weight loss, might also reduce inflammation and improve surgery outcomes.Key Facts
- GLP-1 drugs, like semaglutide and tirzepatide, help control blood sugar and aid weight loss.
- The study analyzed data from over 2 million adults who had elective surgeries lasting more than an hour.
- About 145,610 patients in the study were using GLP-1 medications before surgery.
- GLP-1 users had an 11% lower chance of major heart problems after surgery than non-users.
- They also had an 8% lower chance of infections after surgery compared to non-users.
- Major adverse cardiovascular events (MACE) include heart attack, stroke, and death from any cause.
- Some doctors worry that GLP-1 drugs delay stomach emptying, which could raise risks during anesthesia.
- Current U.S. guidelines recommend deciding individually whether to stop GLP-1 drugs before surgery.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
